By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Visual Analog Scale – Fatigue (VAS-F) for Multiple Sclerosis (MS)
Summary
What it measures:
Fatigue; various versions have been reported:
0‐10 scale: 0=fatigue no problem, 10=fatigue major problem 1, 2
100 mm line: left end of scale=not tired at all, right end of scale=extremely tired 3‐5
50 mm line: left=fatigue worsened as much as possible, right=fatigue completely relieved 6
0‐10 scale: 0=greatest fatigue, 10=less fatigue 7
0‐100 mm line; 3 separate VAS‐F scales; each rates according to left=no influence at all, right=a lot of influence: 8
- VAS‐1: Impact on Daily Life--how much influence does fatigue have on your daily life (the everyday life at home and work) and on your relationships?
- VAS‐2: Impact on Self Care Activities--how much influence does fatigue have on daily activities, like grooming and dressing, etc?
- VAS‐3: Impact on Household and Occupation--how much influence does fatigue have on household or occupational activities?
18 individual 0‐100 mm lines: 13–fatigue subscales, 5‐energy subscales. Left no difficulty, right extremely affected 9
Target Population:
People with multiple sclerosis (MS)
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: January 25, 2015
Contact: practice@apta.org
Content Type: Test & Measure
Fatigue, Multiple Sclerosis, Quality of Life, Infection-Associated Chronic Illness
For MS Outcome Measures Taskforce of APTA Neurology Section: Kathleen Brandfass, PT, MS
You Might Also Like...
CPG
American College of Chest Physicians and Canadian Thoracic Society Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate
CPG
Multiple Sclerosis in Adults: Management [NICE NG220]
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple